Integrated Environmental Technologies, Ltd. (“IET” or the “Company”) (OTC Bulletin Board:IEVM), announced that carbapenem-resistant Enterobacteriaceae (CRE), recently cited in a Centers for Disease Control and Prevention (the “CDC”) Health Advisory, is eliminated by Excelyte®. Specifically, Excelyte® eliminates the two most common types of CRE: Klebsiella pneumonia carbapenemase (KPC) and New Delhi Metallo-Beta Lactamase (NDM)
The new kill claims that relate to healthcare facilities include Klebsiella pneumonia carbapenemase (KPC) and New Delhi Metallo-Beta Lactamase (NDM), Clostridium difficile spores (C. diff), Mycobacterium bovis (Tuberculosis), Vancomycin Resistant Enterococcus (VRE) and Human Immunodeficiency Virus (HIV).
For additional information regarding “Excelyte” and positive disinfecting solution:
